ReShape Lifesciences Inc (NASDAQ:RSLS)’s traded shares stood at 68.87 million during the latest session, with the company’s beta value hitting 1.28. At the last check
ReShape Lifesciences Inc (NASDAQ:RSLS) has a beta value of 1.30 and has seen 19.6 million shares traded in the recent trading session. The company, currently
During the last session, ReShape Lifesciences Inc (NASDAQ:RSLS)’s traded shares were 2.98 million, with the beta value of the company hitting 1.44. At the end
In the last trading session, 5.56 million shares of the ReShape Lifesciences Inc (NASDAQ:RSLS) were traded, and its beta was 1.45. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne